These findings demonstrate an association between ncRuPAR, PAR-1, the PI3K/Akt pathway, and cyclin D1 in human gastric cancer cell proliferation and apoptosis and propose these molecules as potential targets in gastric cancer diagnosis and therapy. This evidence concerns the gene F2R and gastric cancer.